iProtean, now part of Veralon staff will be celebrating the holidays over the next two weeks. We hope you will celebrate as well! Enjoy your holiday season. Very little has changed in the tax reform bill from our report in late November. Here is a summary. Republicans have agreed to preserve tax-exempt, municipal […]
Moody’s Investors Service revised its 2018 outlook for not-for-profit and public health care from stable to negative, according to its recent report. It based its revision on its projections that operating cash flow will contract by 2-4 percent over the next 12-18 months. Revenue growth is under pressure because of very low reimbursement rate […]
(Source: Veralon, a healthcare consulting company providing services in strategic planning, mergers & acquisitions, healthcare valuation and physician compensation, and clinical transformation and value-based payment. Dan Grauman, an iProtean, now part of Veralon expert who appears in many iProtean, now part of Veralon courses, is the managing director and CEO.) In addition to setting […]
The Obama Administration used the Affordable Care Act (ACA) to advance value-based payments. The current administration, however, has been making a series of regulatory changes that “slow or shrink some of these initiatives and let many doctors delay adopting the new system.” Decreased incentives to participate in value-based care and a reduction in reimbursement […]
“As the Trump administration moves to reform the federal tax code, the country’s tax-exempt hospitals are bracing for potential challenges to their not-for-profit (NFP) status, with billions of dollars in federal taxes at stake,” according to the Healthcare Financial Management Association (HFMA) in an article released last week. NFP hospitals face increased scrutiny from […]
The finances of acquired hospitals generally suffer for two years after mergers and acquisitions (M&A), according to a recent report from HFMA and the Deloitte Center for Health Solutions. M&A activity has increased significantly in the past decade, driven by the pursuit of economies of scale and the potential for reducing the cost of […]
Hospital systems and health insurers have very different financing structures. Hospital boards and executive management will want to consider the fundamental differences when considering whether to combine both organizations within the same larger health system. Briefly, the health system has these fundamental financial structure characteristics: Significant physical plant investment Fewer growth opportunities Higher margins, […]
Hospital inpatient drug costs have been rising and this will continue, but at a moderate pace due to public scrutiny of pharmaceutical companies’ drug pricing practices. Moody’s noted in a recent article that even at a slower rate of growth, “we expect rising drug costs will continue to challenge hospitals’ financial flexibility.” (“Not-for-profit and public […]
(The following is an excerpt from “Different Economics, Different Payment: Call Coverage Stipends for Employed vs. Independent Physicians,” Veralon INSIGHTS, September 2017. Dan Grauman, one of our expert presenters, is the Managing Director and CEO of Veralon Healthcare Management Advisors. For the full article, please see the link below.) “Physician employment agreements now commonly […]
Reporting and collecting data for 2017 for the Merit-based Incentive Payment System (MIPS) should be underway in provider organizations. But some may have decided to wait because of what they perceive as high administrative and labor costs. According to experts, these organizations “are well advised to take a closer look at the potential benefits and […]